88 related articles for article (PubMed ID: 23211625)
1. Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo.
Li K; Peers-Adams A; Win SJ; Scullion S; Wilson M; Young VL; Jennings P; Ward VK; Baird MA; Young SL
J Immunother; 2013 Jan; 36(1):11-9. PubMed ID: 23211625
[TBL] [Abstract][Full Text] [Related]
2. Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.
Peacey M; Wilson S; Perret R; Ronchese F; Ward VK; Young V; Young SL; Baird MA
Vaccine; 2008 Oct; 26(42):5334-7. PubMed ID: 18706958
[TBL] [Abstract][Full Text] [Related]
3. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
Peacey M; Wilson S; Baird MA; Ward VK
Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
[TBL] [Abstract][Full Text] [Related]
4. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
Zhang W; He L; Cao X
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
[TBL] [Abstract][Full Text] [Related]
6. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
[TBL] [Abstract][Full Text] [Related]
7. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
8. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
[TBL] [Abstract][Full Text] [Related]
9. Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses.
McKee SJ; Young VL; Clow F; Hayman CM; Baird MA; Hermans IF; Young SL; Ward VK
J Control Release; 2012 May; 159(3):338-45. PubMed ID: 22386518
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
11. Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses.
Kramer K; Al-Barwani F; Baird MA; Young VL; Larsen DS; Ward VK; Young SL
J Immunol Res; 2019; 2019():5364632. PubMed ID: 30729137
[TBL] [Abstract][Full Text] [Related]
12. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
13. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
15. Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).
Zimmermann C; Rawiel M; Blaser C; Kaufmann M; Pircher H
Eur J Immunol; 1996 Dec; 26(12):2903-10. PubMed ID: 8977284
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen.
Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H
Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
18. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
Mazeike E; Gedvilaite A; Blohm U
Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
[TBL] [Abstract][Full Text] [Related]
19. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.
Prévost-Blondel A; Roth E; Rosenthal FM; Pircher H
J Immunol; 2000 Apr; 164(7):3645-51. PubMed ID: 10725721
[TBL] [Abstract][Full Text] [Related]
20. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]